Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherRevenue - OtherShares Issued
Ratios

Nuvation Bio (NUVB-WT) Cost of Revenue (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Cost of Revenue for 2 consecutive years, with -$7.2 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue fell 150.28% to -$7.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $856000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $856000.0 for FY2025, N/A changed from the prior year.
  • Cost of Revenue for Q4 2025 was -$7.2 million at Nuvation Bio, down from $3.3 million in the prior quarter.
  • The five-year high for Cost of Revenue was $3.3 million in Q3 2025, with the low at -$7.2 million in Q4 2025.